COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Disulfiram in Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02678975
Recruitment Status : Active, not recruiting
First Posted : February 10, 2016
Last Update Posted : November 9, 2020
St. Olavs Hospital
Lund University Hospital
Karolinska University Hospital
University Hospital, Linkoeping
Region Örebro County
Ryhov County Hospital
Uppsala University Hospital
Information provided by (Responsible Party):
Asgeir S. Jakola, Sahlgrenska University Hospital, Sweden

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 15, 2021
Estimated Study Completion Date : January 15, 2021
Publications automatically indexed to this study by Identifier (NCT Number):